Listed by the USPTO as YOUNG, MICAH PAUL
Tech Center 1600 • Art Units: 1618 1641
This examiner grants 55% of resolved cases
YOUNG, MICAH PAUL is assigned to Tech Center 1600 and Art Unit 1618. The profile covers 984 resolved cases and reports a 55.2% allowance rate. Interviews are associated with a 30.0% lift in allowance outcomes. The median time to allowance is 1325 days, indicating that applicants should plan prosecution timelines well beyond the initial examination cycle.
The listed companies are The Johns Hopkins University, Antecip Bioventures Ii LLC, and Novartis AG. The listed firms are ARENTFOX SCHIFF LLP, BakerHostetler, and CARTER, DELUCA & FARRELL LLP. The interview measure supports using examiner discussions to identify claim issues before committing to a final amendment strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18988447 | BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS | Non-Final OA | ANTECIP BIOVENTURES II LLC |
| 18103932 | IODINATED COMPOUNDS AND HYDROGELS FORMED FROM SAME | Final Rejection | Boston Scientific Scimed, Inc. |
| 19051618 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT-SOLUBLE ANTI-DANDRUFF AGENTS | Non-Final OA | The Procter & Gamble Company |
| 18011071 | NON-INTUITIVE COMBINATION OF DRUG DELIVERY CARRIERS OF THE SAME DRUG FOR SYNERGISTIC GROWTH DELAY OF SOLID TUMORS | Final Rejection | The Johns Hopkins University |
| 17737229 | INTRANASAL ADMINISTRATION OF GLUTAMATE CARBOXYPEPTIDASE (GCP-II) INHIBITORS | Non-Final OA | The Johns Hopkins University |
| 18249663 | MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING ANTITUMOR T CELL IMMUNITY | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19065875 | METHOD OF CONTROLLING WEEDS | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy55.2% of resolved applications examined by Micah Paul Young were allowed (984 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.
This examiner's interview lift is +30.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Micah Paul Young took 1,325 days on average from filing to allowance.
Micah Paul Young examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
